Bryan Garcia is a Respiratory physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 56 publications with 792 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 6th Ave S
Birmingham, AL 352331801
Telephone
800-822-8816Provider last certified this registry record 10 Mar 2021.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mannkind CorporationProgram year20252 payments
- Insmed, Inc.Program year20255 payments
- Viatris Specialty LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
66.1%Macrolide Antimicrobial35.9%Azithromycin100%Part D≥66 patientsAntimycobacterial11.9%Ethambutol Hcl100%Part D≥28 patients+ 3 more classes in this area
Respiratory
19.7%beta2-Adrenergic Agonist13%Albuterol Sulfate Hfa100%Part D≥31 patientsCorticosteroid6.8%Trelegy Ellipta52%Symbicort48%Part D<11 patientsMetabolism & gastrointestinal
14.1%Corticosteroid7.8%Prednisone100%Part D≥36 patientsProton pump inhibitor3.4%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Remotely addressing health-related social needs (ELICIT) in cystic fibrosis: design and implementation of a multicenter screening and intervention quality improvement project
Therapeutic Advances in Respiratory Disease
2025 - 638 Parameter D: a novel biomarker to detect small airway disease through spirometry in cystic fibrosis
Journal of Cystic Fibrosis
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”